Restoring insulin sensitivity without TZD side effects

Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one of the main hallmarks of the disease.

A popular breast cancer genomic test underestimates risks for Black women

When a woman first learns she has breast cancer, her mind immediately floods with “what now?” questions as she grapples with how this disease will

September 19, 2023

Spexis to file an application for a debt-restructuring moratorium – Biotech Investments

Spexis AG / Key word(s): Strategic Company Decision 08-Nov-2023 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

November 9, 2023

Amid Global Emergency, FDA OKs Another Vaccine for Mpox

On the heels of the World Health Organization’s (WHO) global emergency declaration, the FDA expanded the approval of the smallpox vaccine (ACAM2000) for use in

August 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.